Refine
Has Fulltext
- yes (32)
Is part of the Bibliography
- yes (32)
Year of publication
Document Type
- Journal article (25)
- Doctoral Thesis (7)
Keywords
- phosphorylation (32) (remove)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Institut für Klinische Biochemie und Pathobiochemie (4)
- Institut für Medizinische Strahlenkunde und Zellforschung (3)
- Rudolf-Virchow-Zentrum (3)
- Institut für Klinische Neurobiologie (2)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (2)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Medizinische Klinik und Poliklinik II (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Comprehensive Cancer Center Mainfranken (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 18741 (1)
- 289600 (1)
- 303674 (1)
- 739593 (1)
- FP7-ICT MINIMAL (1)
Ca2+-empfindliche K+-Kanäle mittlerer Leitfähigkeit (IK1-Kanäle) übernehmen wichtige Funktionen bei vielen physiologischen Prozessen wie z.B. bei der Zell-Proliferation, der epithelialen Salz- und Wasser-Sekretion und der Zellmigration. Die Kanäle werden durch die intrazeluläre Ca2+-Konzentration reguliert, wobei ihre Ca2+-Sensitivität durch Phosphorylierungsreaktionen moduliert werden kann. Ziel dieser Arbeit war die funktionelle Charakterisierung des aus transformierten Nierenepithelzellen (MDCK-F-Zellen) klonierten Ca2+-sensitiven K+-Kanals mittlerer Leitfähigkeit (cIK1) und die Untersuchung seiner Regulierung durch die Proteinkinase C (PKC). Dazu wurde der Kanal heterolog in CHO- und HEK293-Zellen exprimiert. Seine biophysikalischen und pharmakologischen Eigenschaften sowie der Einfluß der Proteinkinase C auf die Kanalaktivität wurden mit Hilfe der Patch-Clamp-Technik untersucht. Die cIK1-Ströme sind schwach einwärtsrektifizierend, zeigen keine Aktivierungs- oder Inaktivierungskinetik und weisen im physiologischen Bereich keine Spannungsabhängigkeit auf. Der cIK1 ist K+-selektiv und wird durch einen Anstieg der intrazellulären Ca2+-Konzentration aktiviert. Der Kanal wird durch Barium, Charybdotoxin und Clotrimazol blockiert und durch 1-Ethyl-2-Benzimidazolon aktiviert. Die funktionellen und pharmakologischen Eigenschaften des klonierten cIK1 entsprechen damit denen des nativen Kanals aus MDCK-F-Zellen und stimmen mit denen anderer Mitglieder der IK1-Kanalfamilie überein. Neben der Regulierung durch die intrazelluläre Ca2+-Konzentration wird der cIK1 auch durch eine PKC-abhängige Phosphorylierung reguliert. Sowohl ATP als auch ATP?S stimulieren die Kanalaktivität. Die ATP-abhängige Aktivierung wird durch Inhibitoren der Proteinkinase C (Bisindolylmaleimid, Calphostin C) gehemmt, während die mit ATP?S induzierte Kanalaktivität weitgehend resistent gegen diese PKC-Inhibitoren ist. Eine Stimulierung der Proteinkinase C mit Phorbol 12-Myristat 13-Acetat (PMA) führt zu einer sofortigen Aktivierung des cIK1. Im Gegensatz dazu sind die cIK1-Kanäle nach fast vollständigem Abbau der Proteinkinase C durch eine langfristige Inkubierung der Zellen mit PMA nicht mehr aktiv. Um zu untersuchen, ob diese Regulierung eine direkte Interaktion der Proteinkinase C mit dem Kanalprotein erfordert, wurden die drei putativen PKC-Konsensussequenzen des cIK1 mittels zielgerichteter Mutagenese so verändert, daß eine Phosphorylierung an diesen Stellen nicht mehr möglich ist. Weder die einzelne Mutation der PKC-Konsensussequenzen (T101, S178, T329) noch die gleichzeitige Mutation aller drei Phosporylierungsstellen zu Alanin beeinflußt die akute Regulierung des cIK1 durch die Proteinkinase C. Die cIK1-Mutante T329A und die Dreifachmutante reagieren jedoch nach einem Abbau der Proteinkinase C mit einem extremen Anstieg der Kanalaktivität und demaskieren damit einen zweiten Weg der Kanalregulierung. Die Ergebnisse zeigen, daß der cIK1 durch zwei voneinander unabhängige Mechanismen reguliert wird. Eine PKC-abhängige Phosphorylierung erhöht die Aktivität der Kanäle, findet jedoch nicht an den bekannten PKC-Konsensusesquenzen des Kanalproteins statt. Dagegen werden die cIK1-Kanäle über einen zweiten ATP-abhängigen Mechanismus, der wahrschenlich eine direkte Interaktion mit dem Kanalprotein erfordert, gehemmt.
GRK2 wird an Serin29 durch PKC phosphoryliert. Die Phosphorylierung verhindert die Inhibition der GRK2 durch Calmodulin. Die Inhibition der GRK2 durch Calmodulin wird durch den N-Terminus der GRK2 vermittelt und ist auf eine gestörte Aktivierbarkeit der GRK2 durch G-Protein beta/gamma-Untereinheiten zurückzuführen.
In mammals, the RAF family of serine/threonine kinases consists of three members, A-, B- and C-RAF. Activation of RAF kinases involves a complex series of phosphorylations. Although the most prominent phosphorylation sites of B- and C-RAF are well characterized, little is known about regulatory phosphorylation of A-RAF. Using mass spectrometry, we identified here a number of novel in vivo phosphorylation sites in A-RAF. The physiological role and the function of these sites were investigated subsequently by amino acid exchange at the relevant positions. In particular, we found that S432 participates in MEK binding and is indispensable for A-RAF signaling. On the other hand, phosphorylation within the activation segment does not contribute to epidermal growth factor-mediated activation. Regarding regulation of A-RAF activity by 14-3-3 proteins, we show that A-RAF activity is regulated differentially by its C-terminal and internal 14-3-3 binding domain. Furthermore, by use of SPR technique, we found that 14-3-3 proteins associate with RAF in an isoform-specific manner. Of importance, we identified a novel regulatory domain in A-RAF (referred to as IH-segment) positioned between amino acids 248 and 267, which contains seven putative phosphorylation sites. Three of these sites, serines 257, 262 and 264, regulate A-RAF activation in a stimulatory manner. The spatial model of the A-RAF fragment including residues between S246 and E277 revealed a “switch of charge” at the molecular surface of the IH-region upon phosphorylation, suggesting a mechanism in which the high accumulation of negative charges may lead to an electrostatic destabilization of protein/membrane interaction resulting in depletion of A-RAF from the plasma membrane. Activation of B- and C-RAF is regulated by phosphorylation at conserved residues within the negative-charge regulatory region (N-region). Identification of phosphopeptides covering the sequence of the N-region led to the conclusion that, similar to B- and C-RAF, kinase activity of A-RAF is regulated by phosphorylation of the N-region. Abrogation of A-RAF activity by S299A substitution and elevated activity of the A-RAF-Y301D-Y302D mutant confirmed this conclusion. In addition, we studied the role of the non-conserved residues within the N-region in the activation process of RAF kinases. The non-conserved amino acids in positions –3 and +1 relative to the highly conserved S299 in A-RAF and S338 in C-RAF have so far not been considered as regulatory residues. Here, we demonstrate that Y296R substitution in A-RAF led to a constitutively active kinase. In contrast, G300S substitution (mimicking B- and C-RAF) acts in an inhibitory manner. These data were confirmed by analogous mutations in C-RAF. Based on the three-dimensional structure of the catalytic domain of B-RAF, a tight interaction between the N-region residue S339 and the catalytic domain residue R398 was identified in C-RAF and proposed to inhibit the kinase activity of RAF proteins. Furthermore, Y296 in A-RAF favors a spatial orientation of the N-region segment, which enables a tighter contact to the catalytic domain, whereas a glutamine residue at this position in C-RAF abrogates this interaction. Considering this observation, we suggest that Y296, which is unique for A-RAF, is a major determinant of the low activating potency of this RAF isoform. Finally, the residues R359 in A-RAF and R398 in C-RAF, which interact with the N-region, are also involved in binding of phosphatidic acid. Substitution of this conserved arginine by alanine resulted in accumulation of hyper-phosphorylated form of RAF, suggesting that this residue play a crucial role in phosphorylation-mediated feedback regulation of A- and C-RAF. Collectively, we provide here for the first time a detailed analysis of in vivo A-RAF phosphorylation status and demonstrate that regulation of A-RAF by phosphorylation exhibits unique features compared with B- and C-RAF.
Electrophysiological analyses conducted about 25 years ago detected two types of anion channels in the plasma membrane of guard cells. One type of channel responds slowly to changes in membrane voltage while the other responds quickly. Consequently, they were named SLAC, for SLow Anion Channel, and QUAC, for QUick Anion Channel. Recently, genes SLAC1 and QUAC1/ALMT12, underlying the two different anion current components, could be identified in the model plant Arabidopsis thaliana. Expression of the gene products in Xenopus oocytes confirmed the quick and slow current kinetics. In this study we provide an overview on our current knowledge on slow and quick anion channels in plants and analyze the molecular evolution of ALMT/QUAC-like and SLAC-like channels. We discovered fingerprints that allow screening databases for these channel types and were able to identify 192 (177 non-redundant) SLAC-like and 422 (402 non-redundant) ALMT/QUAC-like proteins in the fully sequenced genomes of 32 plant species. Phylogenetic analyses provided new insights into the molecular evolution of these channel types. We also combined sequence alignment and clustering with predictions of protein features, leading to the identification of known conserved phosphorylation sites in SLAC1-like channels along with potential sites that have not been yet experimentally confirmed. Using a similar strategy to analyze the hydropathicity of ALMT/QUAC-like channels, we propose a modified topology with additional transmembrane regions that integrates structure and function of these membrane proteins. Our results suggest that cross-referencing phylogenetic analyses with position-specific protein properties and functional data could be a very powerful tool for genome research approaches in general.
LASP-1 (LIM und SH3 Domänen Protein) ist ein in Zellen ubiquitär vorkommendes Protein, welches in verschiedenen Tumorgeweben eine pathophysiologische Überexpression aufweist. Das Protein besitzt eine LIM Domäne, zwei Aktinbindungsregionen sowie eine SH3 Domäne und bindet einerseits an dynamischen Aktinstrukturen wie den fokalen Kontakten, Lamellopodien und Membranfortsätzen, kann andererseits aber auch in den Zellkern translokalisieren. Für Aktinstrukturen wirkt LASP-1 als Gerüstprotein und ist wichtig für die Migration und Proliferation der Zellen. Die Funktion von LASP-1 im Zellkern ist noch nicht bekannt, da aber in Tumorzellen eine erhöhte nukleare Akkumulation von LASP-1 beobachtet werden konnte, deren Intensität mit der Tumorgröße sowie dem Langzeitüberleben der Patientinnen korreliert, ist LASP-1, zusätzlich zu seiner Funktion als Strukturprotein, vermutlich auch ein Transkriptionsfaktor oder ein transkriptioneller Kofaktor. Eine Herunterregulation von LASP-1 in verschiedenen Tumorentitäten führt zur Inhibition der Proliferation und Migration. In dieser Arbeit konnte der bisher unbekannte Zellkernimport und -export von LASP-1 aufgeklärt werden. Maßgeblich daran beteiligt ist ein durch Pulldown Experimente neu identifizierter LASP-1 Bindungspartner: das Zonula Occludens 2 Protein (ZO-2). Mittels Immunpräzipitationen und Immunfluoreszenzen wurde diese Interaktion bestätigt. Nach Phosphorylierung von LASP-1 an Ser-146 durch Aktivierung der cAMP-abhängigen Proteinkinase (PKA) kommt es zu einer partiellen Ablösung des LASP-1/ZO-2 Komplexes aus den fokalen Kontakten hin zu einer vermehrten Kernlokalisation beider Proteine. Dies lässt sich durch Kern/Zytosol Trennungen belegen. Dabei ist die Bindung von LASP-1 an ZO-2 essentiell für die Translokation in den Zellkern, da bei einem ZO-2 Knockdown auch nach PKA Aktivierung LASP-1 zytosolisch lokalisiert bleibt. Wie Mutationsanalysen zeigen, findet die Interaktion zwischen der C-terminalen SH3 Domäne im LASP-1 und der Prolin-reichen SH3-Bindungssequenz im Bereich der Aminosäuren 1103-1121 am C-Terminus im ZO-2 statt. Die Translokation des Komplexes in den Kern erfolgt dabei über das Kernlokalisationssignal im ZO-2, da die LASP-1 Sequenz selbst keine nukleare Importsequenz aufweist. Im Zellkern konnte die direkte Interaktion von LASP-1 und ZO-2 mittels Duolink® Proximity Ligation Assay sichtbar gemacht werden. Der Export der Proteine erfolgt über das Protein CRM1. Eine Inhibition der Kernexportmaschinerie mit Leptomycin B erhöht die Konzentration beider Proteine im Zellkern. Das nukleare Exportsignal (NES) im LASP-1 konnte durch Punktmutationen N-terminal der Leucin-reichen Aminosäuresequenz 70-77 zugeordnet werden (NLRLKQQS). Im letzten Schritt dieses Zyklus erfolgt die Relokalisation von LASP-1 zurück an die Zellmembranstrukturen. Der neu gefundene Signalweg dient wahrscheinlich zur Weiterleitung von externen Stimuli in den Kern und zur Genregulation - mit LASP-1 als Transkriptionsfaktor oder transkriptionellen Kofaktor.
Eukaryotic cells form a variety of adhesive structures to connect with their environment and to regulate cell motility. In contrast to classical focal adhesions, podosomes, highly dynamic structures of different cell types, are actively engaged in matrix remodelling and degradation. Podosomes are composed of an actin-rich core region surrounded by a ring-like structure containing signalling molecules, motor proteins as well as cytoskeleton-associated proteins. Lasp-1 is a ubiquitously expressed, actin-binding protein that is known to regulate cytoskeleton architecture and cell migration. This multidomain protein is predominantely present at focal adhesions, however, a second pool of Lasp-1 molecules is also found at lamellipodia and vesicle-like microdomains in the cytosol. In this report, we show that Lasp-1 is a novel component and regulator of podosomes. Immunofluorescence studies reveal a localization of Lasp-1 in the podosome ring structure, where it colocalizes with zyxin and vinculin. Life cell imaging experiments demonstrate that Lasp-1 is recruited in early steps of podosome assembly. A siRNA-mediated Lasp-1 knockdown in human macrophages affects podosome dynamics as well as their matrix degradation capacity. In summary, our data indicate that Lasp-1 is a novel component of podosomes and is involved in the regulation of podosomal function.
The CK2 Kinase Stabilizes CLOCK and Represses Its Activity in the Drosophila Circadian Oscillator
(2013)
Phosphorylation is a pivotal regulatory mechanism for protein stability and activity in circadian clocks regardless of their evolutionary origin. It determines the speed and strength of molecular oscillations by acting on transcriptional activators and their repressors, which form negative feedback loops. In Drosophila, the CK2 kinase phosphorylates and destabilizes the PERIOD (PER) and TIMELESS (TIM) proteins, which inhibit CLOCK (CLK) transcriptional activity. Here we show that CK2 also targets the CLK activator directly. Downregulating the activity of the catalytic alpha subunit of CK2 induces CLK degradation, even in the absence of PER and TIM. Unexpectedly, the regulatory beta subunit of the CK2 holoenzyme is not required for the regulation of CLK stability. In addition, downregulation of \(CK2\alpha\) activity decreases CLK phosphorylation and increases per and tim transcription. These results indicate that CK2 inhibits CLK degradation while reducing its activity. Since the CK1 kinase promotes CLK degradation, we suggest that CLK stability and transcriptional activity result from counteracting effects of CK1 and CK2.
Multiple myeloma (MM) displays an NFκB activity-related gene expression signature and about 20% of primary MM samples harbor genetic alterations conducive to intrinsic NFκB signaling activation. The relevance of blocking the classical versus the alternative NFκB signaling pathway and the molecular execution mechanisms involved, however, are still poorly understood. Here, we comparatively tested NFκB activity abrogation through TPCA-1 (an IKK2 inhibitor), BAY 11-7082 (an IKK inhibitor poorly selective for IKK1 and IKK2), and MLN4924 (an NEDD8 activating enzyme (NAE)-inhibitor), and analyzed their anti-MM activity. Whereas TPCA-1 interfered selectively with activation of the classical NFκB pathway, the other two compounds inhibited classical and alternative NFκB signaling without significant discrimination. Noteworthy, whereas TPCA-1 and MLN4924 elicited rather mild anti-MM effects with slight to moderate cell death induction after 1 day BAY 11-7082 was uniformly highly toxic to MM cell lines and primary MM cells. Treatment with BAY 11-7082 induced rapid cell swelling and its initial effects were blocked by necrostatin-1 or the ROS scavenger BHA, but a lasting protective effect was not achieved even with additional blockade of caspases. Because MLN4924 inhibits the alternative NFκB pathway downstream of IKK1 at the level of p100 processing, the quite discordant effects between MLN4924 and BAY 11-7082 must thus be due to blockade of IKK1-mediated NFκB-independent necrosis-inhibitory functions or represent an off-target effect of BAY 11-7082. In accordance with the latter, we further observed that concomitant knockdown of IKK1 and IKK2 did not have any major short-term adverse effect on the viability of MM cells.
Many pathogenic bacteria cause local infections but occasionally invade into the blood stream, often with fatal outcome. Very little is known about the mechanism underlying the switch from local to invasive infection. In the case of Neisseria gonorrhoeae, phase variable type 4 pili (T4P) stabilize local infection by mediating microcolony formation and inducing anti-invasive signals. Outer membrane porin PorBIA, in contrast, is associated with disseminated infection and facilitates the efficient invasion of gonococci into host cells. Here we demonstrate that loss of pili by natural pilus phase variation is a prerequisite for the transition from local to invasive infection. Unexpectedly, both T4P-mediated inhibition of invasion and PorBIA-triggered invasion utilize membrane rafts and signaling pathways that depend on caveolin-1-Y14 phosphorylation (Cav1-pY14). We identified p85 regulatory subunit of PI3 kinase (PI3K) and phospholipase Cγ1 as new, exclusive and essential interaction partners for Cav1-pY14 in the course of PorBIA-induced invasion. Active PI3K induces the uptake of gonococci via a new invasion pathway involving protein kinase D1. Our data describe a novel route of bacterial entry into epithelial cells and offer the first mechanistic insight into the switch from local to invasive gonococcal infection.
Caffeine administration is an important part of the therapeutic treatment of bronchopulmonary dysplasia (BPD) in preterm infants. However, caffeine mediated effects on airway remodelling are still undefined. The TGF-β/Smad signalling pathway is one of the key pathways involved in airway remodelling. Connective tissue growth factor (CTGF), a downstream mediator of TGF-β, and transgelin, a binding and stabilising protein of the cytoskeleton, are both regulated by TGF-b1 and play an important role in airway remodelling. Both have also been implicated in the pathogenesis of BPD. The aim of the present study was to clarify whether caffeine, an unspecific phosphodiesterase (PDE) inhibitor, and rolipram, a prototypical PDE-4 selective inhibitor, were both able to affect TGF-β1-induced Smad signalling and CTGF/transgelin expression in lung epithelial cells. Furthermore, the effect of transgelin knock-down on Smad signalling was studied. The pharmacological effect of caffeine and rolipram on Smad signalling was investigated by means of a luciferase assay via transfection of a TGFβ1- inducible reporter plasmid in A549 cells. The regulation of CTGF and transgelin expression by caffeine and rolipram were studied by promoter analysis, real-time PCR and Western blot. Endogenous transgelin expression was down-regulated by lentiviral transduction mediating transgelin-specific shRNA expression. The addition of caffeine and rolipram inhibited TGFβ1 induced reporter gene activity in a concentration-related manner. They also antagonized the TGF-b1 induced upregulation of CTGF and transgelin on the promoter-, the mRNA-, and the protein-level. Functional analysis showed that transgelin silencing reduced TGF-β1 induced Smad-signalling and CTGF induction in lung epithelial cells. The present study highlights possible new molecular mechanisms of caffeine and rolipram including an inhibition of Smad signalling and of TGF-β1 regulated genes involved in airway remodelling. An understanding of these mechanisms might help to explain the protective effects of caffeine in prevention of BPD and suggests rolipram to be a potent replacement for caffeine.